Related Experiment Videos
Tumor-induced immunosuppression
The American Journal of Pathology
|November 1, 1978
Abstract:
Three tumor systems, including a mastocytoma, plasmacytomas, and a leukemia-lymphoma were studied for their ability to modify humoral immunity to sheep erythrocytes both in vivo and in vitro. All tumors resulted in a depression of the hemolytic antibody plaque-forming cell response in susceptible mice. These studies indicated that the mechanism(s) of suppression, although not fully defined, were different for each model system investigated.
Insights
Tumors like mastocytoma, plasmacytomas, and leukemia-lymphoma suppress immune responses to sheep red blood cells. The exact mechanisms of this immune suppression varied across the different tumor types studied.
Area of Science:
- Immunology
- Oncology
Background:
- Humoral immunity is crucial for fighting infections.
- Cancer can significantly impair the immune system's ability to function.
Purpose of the Study:
- To investigate how different tumor types affect the immune response to sheep erythrocytes.
- To compare the immune suppression mechanisms across mastocytoma, plasmacytomas, and leukemia-lymphoma models.
Main Methods:
- Studied three distinct tumor systems: mastocytoma, plasmacytomas, and leukemia-lymphoma.
- Assessed the hemolytic antibody plaque-forming cell response in vivo and in vitro.
- Utilized susceptible mouse models for experimental analysis.
Main Results:
- All three tumor models demonstrated a significant depression of the antibody-producing cell response.
- The observed immune suppression was evident in both in vivo and in vitro experimental settings.
- Each tumor system exhibited unique characteristics in its impact on humoral immunity.
Conclusions:
- Mastocytoma, plasmacytomas, and leukemia-lymphoma negatively impact humoral immunity.
- The mechanisms underlying tumor-induced immune suppression are diverse and tumor-specific.
- Further research is needed to fully elucidate the distinct pathways of immunosuppression.